-
Wegovy-maker Novo Nordisk extends curb on provide of weight-loss drug, raises outlook

A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk, which makes blockbuster drug Wegovy, raised its outlook for 2023 Thursday but said it is extending supply restrictions for some doses of the weight-loss drug. The Danish pharmaceutical…
-
Listed below are the 5 price-target modifications and Four trades we made throughout this busy earnings week

In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for some of our biggest stocks. Many of these moves stemmed from what we saw in quarterly numbers and heard on conference calls. Here’s a day-by-day look at the portfolio action. Monday The week began with our decision to exit…
-
Pfizer (PFE) Q2 earnings report 2023

Pavlo Gonchar | Lightrocket | Getty Images Pfizer on Tuesday reported second-quarter adjusted earnings that topped Wall Street’s expectations, but posted revenue that fell short of estimates as Covid product sales plunged. Pfizer reported second-quarter sales of $12.73 billion, down 54% over the same period a year ago. Excluding sales of the company’s Covid vaccine…
-
New invoice goals to assist low-income folks with disabilities get monetary savings

Halfpoint Images | Moment | Getty Images The Americans with Disabilities Act was signed into law 33 years ago to protect people with disabilities from discrimination. But disabled people still face major hurdles when it comes to building wealth. To help make it easier for disabled individuals with lower incomes to save, Sen. Bob Casey,…
-
Why Most Customers Ignore Well being Warnings

Warning labels are intended to inform consumers of potential risks when using a product, but they are too widespread to be of any use. “Warning labels were actually pretty rare up until the 1960s,” said W. Kip Viscusi, a distinguished professor of law, economics, and management at Vanderbilt University. “From the mid-1960s, cigarettes were labeled…
-
Medicare proposes broader protection of PET scans

Jay Reinstein, who has Alzheimer’s disease, sits on a bed after undergoing a PET scan at MedStar Georgetown University Hospital on June 20, 2023 in Washington, DC. Michael Robinson Chavez | The Washington Post | Getty Images Medicare plans to expand coverage of PET scans used to diagnose Alzheimer’s disease. This is an important policy…
-
Uninsured folks pay excessive prices for insulin. Eli Lilly vowed to decrease them

A pharmaceutical manufacturing facility owned by Eli Lilly and Company is pictured March 5, 2021 in Branchburg, New Jersey. Fresh Mike | Reuters On average, uninsured Americans pay nearly $98 for a vial Eli LillyThe company promised to lower the product’s list price to $25 per vial, according to a report released Thursday by Senator…
-
What sufferers and docs ought to know

Alzheimer’s drug Leqembi can be seen in this undated handout picture obtained by Reuters on January 20, 2023. Eisai | via Reuters Medicare has agreed to fund Leqembi’s Alzheimer’s treatment, a major game-changer for patients diagnosed with the disease in its early stages. Leqembi is currently the only drug on the market that has been…
-
Nike CEO John Donahoe on how he is managing sleep well being in a busy life

For corporate executives in America, sleep is often that rare luxury they don’t have or can’t buy. Success, especially early success, rarely comes without a few nights, but there’s a realization among the most well-known market leaders that burning the night oil isn’t a smart long-term strategy for productivity. “I’ve tried to sleep less, but…
-
Medicare will enable drug corporations to barter drug costs

Hundreds of 1199SEIU healthcare workers held a rally and blocked 3rd Avenue where some were arrested. They were protesting health care cuts in Gov. Kathy Hochul’s Medicare budget. Lev Radin | flare | Getty Images Medicare announced Friday that it will give drug companies an opportunity to publicly discuss historic drug pricing negotiations under the…